Cronos Group Inc. (CRON)
NASDAQ: CRON · IEX Real-Time Price · USD
2.380
+0.030 (1.28%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Cronos Group Revenue

Cronos Group had revenue of $93.03M in the twelve months ending March 31, 2024, with 11.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $25.29M with 29.72% year-over-year growth. In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth.

Revenue (ttm)
$93.03M
Revenue Growth
+11.37%
P/S Ratio
9.77
Revenue / Employee
$261,331
Employees
356
Market Cap
909.19M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202387.24M492.00K0.57%
Dec 31, 202286.75M22.19M34.37%
Dec 31, 202164.56M17.84M38.19%
Dec 31, 202046.72M22.97M96.71%
Dec 31, 201923.75M11.63M95.94%
Dec 31, 201812.12M8.97M285.16%
Dec 31, 20173.15M2.72M638.69%
Dec 31, 2016426.03K--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacira BioSciences 681.75M
HealthStream 282.88M
CareDx 275.11M
Harrow Health 138.68M
AbCellera Biologics 35.79M
AnaptysBio 22.96M
Viridian Therapeutics 288.00K
Perspective Therapeutics -304.00K
Revenue Rankings